CSI Market
Sign In | Register

Better Therapeutics Inc (BTTX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BTTX Annual Cash Flow →
Looking at cash flow data from Better Therapeutics Inc through Sep 30 2022 provides insight into Sep 30 2023's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2023)
9 Months 		(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Operating Activities
Income-22.81
Depreciation & amortization2.39
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.32
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Gain Loss Due To Change In Fair Value Of Simple Agreement For Future Equity-
Tangible Asset Impairment Charges0.01
Gain Loss On Loan Forgiveness-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable, Trade-0.73
Increase (Decrease) in Accrued Liabilities-1.88
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.97
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-19.75
Investing Activities
Capital Expenditures-0.96
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.96
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.86
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock12.42
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Net Proceeds From Initial Public Offering-
Units Issued During Period Value Issuance Through Private Placement-
Proceeds From Issuance Of Simple Agreement For Future Equity Notes Value-
Proceeds From Business Combination And Private Investment In Public Equity Investment-
Payment Of Business Combination And Private Investment In Public Equity Investment Cost-
Proceeds From Issuance Of Long Term Debt Excluding Convertible Debt5.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities11.56
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-20.70
Total Cash Flow-9.14
4 historic quarters locked

Sign in to unlock the full Better Therapeutics Inc cash flow history.

Sign In Create Free Account

About Better Therapeutics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-23-061515

Figures are derived from filed reports and may be restated. Historical data is subject to revision.